|
[1]
|
Mebendazole in simultaneous combination with dexamethasone- (C21-phosphoramidate)-[anti-EGFR] generated utilizing a novel synthesis regimen: dual anti …
|
|
2019 |
|
|
|
|
[2]
|
Carnosic Acid, Tangeretin, and Ginkgolide-B Anti-neoplastic Cytotoxicity in Dual Combination with Dexamethasone-[anti-EGFR] in Pulmonary Adenocarcinoma (A549 …
|
|
2019 |
|
|
|
|
[3]
|
Anti-neoplastic cytotoxicity by complementary simultaneous selective “targeted” delivery for pulmonary adenocarcinoma: fludarabine-(5′-phosphoramidate)-[anti-IGF-1R] in dual …
|
|
Journal of Pharmaceutical Investigation,
2018 |
|
|
|
|
[4]
|
Selectively Targeted Anti-Neoplastic Cytotoxicity of Three Immunopharmaceuticals with Covalently Bound Fludarabine, Gemcitabine and Dexamethasone Moieties …
|
|
Current Pharmaceutical Design,
2018 |
|
|
|
|
[5]
|
Gemcitabine‐(5′‐phosphoramidate)‐[anti‐IGF‐1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of …
|
|
Chemical biology & drug design,
2017 |
|
|
|
|
[6]
|
Gemcitabine‐(5'‐phosphoramidate)‐[anti‐IGF‐1R]: Molecular Design, Synthetic Organic Chemistry Reactions, and Antineoplastic Cytotoxic Potency in Populations of …
|
|
Chemical biology & drug design,
2016 |
|
|
|
|
[7]
|
Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against …
|
|
Drug design, development and therapy,
2016 |
|
|
|
|
[8]
|
Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against …
|
|
Drug design, development and therapy,
2016 |
|
|
|
|
[9]
|
Fludarabine-(C2-methylhydroxyphosphoramide)-[anti-IGF-1R]: Synthesis and Selectively “Targeted” Anti-Neoplastic Cytotoxicity against Pulmonary Adenocarcinoma (A549)
|
|
Journal of pharmaceutics & drug delivery research,
2015 |
|
|
|
|
[10]
|
Simultaneous Dual Selective Targeted Delivery of Two Covalent Gemcitabine Immunochemotherapeutics and Complementary Anti-Neoplastic Potency of [Se] …
|
|
Journal of cancer therapy,
2015 |
|
|
|
|
[11]
|
Simultaneous Dual Selective Targeted Delivery of Two Covalent Gemcitabine Immunochemotherapeutics and Complementary Anti-Neoplastic Potency of [Se] …
|
|
Journal of cancer therapy,
2015 |
|
|
|
|
[12]
|
Fludarabine-(C2-methylhydroxyphosphoramide)-[anti-IGF-1R]: synthesis and selectively “targeted” anti-neoplastic cytotoxicity against pulmonary …
|
|
Journal of pharmaceutics & drug delivery research,
2015 |
|
|
|
|
[13]
|
Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3-amide)-[anti-HER2/neu] against …
|
|
Medicinal chemistry,
2014 |
|
|
|
|
[14]
|
Simultaneous Dual Selective Targeted Delivery of Two Covalent Gemcitabine Immunochemotherapeutics and Complementary Anti-Neoplastic Potency of [Se]-Methylselenocysteine
|
|
Journal of Cancer Therapy,
2014 |
|
|
|
|
[15]
|
Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3-amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole
|
|
Journal of cancer research and therapeutic oncology,
2014 |
|
|
|
|
[16]
|
Gemcitabine-(C4-amide)-[anti-HER2/neu] Anti-Neoplastic Cytotoxicity in Dual Combination with Mebendazole against Chemotherapeutic-Resistant Mammary Adenocarcinoma
|
|
Journal of Clinical & Experimental Oncology,
2013 |
|
|
|
|
[17]
|
Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-HER2/neu] in Combination with Griseofulvin against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3)
|
|
Medicinal Chemistry,
2013 |
|
|
|
|
[18]
|
Gemcitabine-(C4-amide)-[anti-HER2/neu] Anti-Neoplastic Cytotoxicity in Dual Combination with Mebendazole against Chemotherapeutic-Resistant Mammary …
|
|
Journal of clinical & experimental oncology,
2013 |
|
|
|
|
[19]
|
Anti-neoplastic cytotoxicity of gemcitabine-(C4-amide)-[anti-HER2/neu] in combination with Griseofulvin against chemotherapeutic-resistant mammary …
|
|
Medicinal chemistry,
2013 |
|
|
|
|
[20]
|
Gemcitabine-(C4-amide)-[anti-HER2/neu] anti-neoplastic cytotoxicity in dual combination with mebendazole against chemotherapeutic-resistant mammary …
|
|
Journal of clinical & experimental oncology,
2013 |
|
|
|
|
[21]
|
Anti-neoplastic cytotoxicity of gemcitabine-(C4-amide)-[anti-HER2/neu] in combination with Griseofulvin against chemotherapeutic-resistant mammary …
|
|
Medicinal chemistry,
2013 |
|
|
|